Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Vivanza Biosciences Ltd (NSE: VIVANZA), ISIN INE984E01035 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
VIVANZA last traded at ₹1.80 (-2.70%), with a 52-week range of ₹1.52 to ₹2.72 (as of 23 Sep 2026).
Shareholding as of Dec 2025: promoters 20.02%, FIIs 0.00%, DIIs 0.00%, mutual funds 0.00%.
EquiSense Score (ECS): 38/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.